Genetics of Severe Cutaneous Adverse Reactions

被引:12
|
作者
Yang, Shang-Chen [1 ]
Chen, Chun-Bing [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
Lin, Mao-Ying [1 ]
Zhang, Zhi-Yang [1 ]
Jia, Xiao-Yan [8 ]
Huang, Ming [8 ]
Zou, Ya-Fen [8 ]
Chung, Wen-Hung [1 ,2 ,3 ,4 ,5 ,7 ,9 ,10 ,11 ]
机构
[1] Xiamen Chang Gung Hosp, Dept Dermatol, Xiamen Chang Gung Allergol Consortium, Xiamen, Peoples R China
[2] Chang Gung Mem Hosp, Drug Hypersensit Clin & Res Ctr, Dept Dermatol, Taoyuan, Taiwan
[3] Chang Gung Mem Hosp, Canc Vaccine & Immune Cell Therapy Core Lab, Dept Med Res, Taoyuan, Taiwan
[4] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
[5] Chang Gung Mem Hosp, Whole Genome Res Core Lab Human Dis, Keelung, Taiwan
[6] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan
[7] Chang Gung Mem Hosp, Immune Oncol Ctr Excellence, Linkou, Taiwan
[8] Xiamen Chang Gung Hosp, Dept Neurol, Xiamen, Peoples R China
[9] Tsinghua Univ, Beijing Tsinghua Chang Gung Hosp, Sch Clin Med, Dept Dermatol, Beijing, Peoples R China
[10] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Dermatol, Shanghai, Peoples R China
[11] Chang Gung Mem Hosp, Genom Med Core Lab, Linkou, Taiwan
关键词
genetic screen; Stevens-Johnson syndrome; toxic epidermal necrolysis; pharmacogenomic; severe cutaneous adverse drug reactions; STEVENS-JOHNSON-SYNDROME; TOXIC EPIDERMAL NECROLYSIS; GENOME-WIDE ASSOCIATION; HLA-DEPENDENT HYPERSENSITIVITY; SEVERE OCULAR COMPLICATIONS; SYSTEMIC SYMPTOMS DRESS; CLASS-I GENES; HLA-B-ASTERISK-1502; ALLELE; DRUG-REACTIONS; COLD MEDICINE;
D O I
10.3389/fmed.2021.652091
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Severe cutaneous adverse reactions (SCARs) including Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug rash with eosinophilia and systemic symptoms (DRESS) are T cells-mediated life-threatening immune reactions, most commonly induced by drug. The last decade has seen significant progress in SCARs research. Recent studies have unveiled the pathogenesis of SCARs involved in susceptible genes, including human leukocyte antigens (HLA) and drugs-T cell receptor (TCR) interaction that may trigger T cell activation with downstream immune signaling of cytokines/chemokines and specific cytotoxic proteins releases. Advances in identification of multiple genetic alleles associated with specific drugs related SCARS in different populations is an important breakthrough in recent years for prevention of SCARs. This article summarized the findings on genetic factors related to SJS/TEN, especially for HLA.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Severe cutaneous adverse reactions: impact of immunology, genetics, and pharmacology
    Harp, Joanna L.
    Kinnebrew, Melissa A.
    Shinkai, Kanade
    SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2014, 33 (01) : 17 - 27
  • [2] Pharmacogenomics of severe cutaneous adverse reactions
    Kaniwa, Nahoko
    Saito, Yoshiro
    PHARMACOGENOMICS, 2013, 14 (06) : 595 - 598
  • [3] Severe cutaneous adverse drug reactions
    Chung, Wen-Hung
    Wang, Chuang-Wei
    Dao, Ro-Lan
    JOURNAL OF DERMATOLOGY, 2016, 43 (07) : 758 - 766
  • [4] Severe cutaneous adverse reactions
    Hung, Shuen-Iu
    Mockenhaupt, Maja
    Blumenthal, Kimberly G.
    Abe, Riichiro
    Ueta, Mayumi
    Ingen-Housz-Oro, Saskia
    Phillips, Elizabeth J.
    Chung, Wen-Hung
    NATURE REVIEWS DISEASE PRIMERS, 2024, 10 (01)
  • [5] Genetic markers of severe cutaneous adverse reactions
    Jung, Jae-Woo
    Kim, Jae-Yeol
    Park, In-Won
    Choi, Byoung-Whui
    Kang, Hye-Ryun
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2018, 33 (05) : 867 - 875
  • [6] Treatments for Severe Cutaneous Adverse Reactions
    Cho, Yung-Tsu
    Chu, Chia-Yu
    JOURNAL OF IMMUNOLOGY RESEARCH, 2017, 2017
  • [7] Severe cutaneous adverse reactions to drugs
    Tu Anh Duong
    Valeyrie-Allanore, Laurence
    Wolkenstein, Pierre
    Chosidow, Olivier
    LANCET, 2017, 390 (10106) : 1996 - 2011
  • [8] Pharmacogenetic markers of severe cutaneous adverse drug reactions
    Borroni, R. G.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2014, 149 (02): : 219 - 226
  • [9] Treatment of severe cutaneous adverse drug reactions
    Ingen-Housz-Oro, S.
    Duong, T-A
    de Prost, N.
    Colin, A.
    Fardet, L.
    Lebrun-Vignes, B.
    Barbaud, A.
    Chosidow, O.
    Wolkenstein, P.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2018, 145 (6-7): : 454 - 464
  • [10] Approach to Severe Cutaneous Adverse Drug Reactions
    Bellón T.
    Cabañas R.
    González-Herrada C.
    Ramírez E.
    González-Ramos J.
    López San Martín M.
    González-Valle O.
    Fiandor A.M.
    Lerma V.
    Roustan G.
    de Abajo F.
    Current Treatment Options in Allergy, 2017, 4 (2) : 201 - 221